Phosphorylethanolamine: Difference between revisions

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 16:23, 2 April 2016 editRod57 (talk \| contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers32,748 editsm →Research: [[← Previous edit		Revision as of 16:09, 9 April 2016 edit undoFgnievinski (talk \| contribs)Autopatrolled, Extended confirmed users66,936 edits Citing Nature and Science about controversial cancer treatment allegations in Brazil.Next edit →
Line 44:		Line 44:
	==Research==		==Research==
	Research is being conducted with ] cells in-vitro to see if phosphoethanolamine could be used in cancer treatment.<ref>{{Cite journal\|title = Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study\|url = http://www.ncbi.nlm.nih.gov/pubmed/22213293\|journal = Anticancer Research\|date = 2012-01-01\|issn = 1791-7530\|pmid = 22213293\|pages = 95-104\|volume = 32\|issue = 1\|first = Adilson Kleber\|last = Ferreira\|first2 = Renato\|last2 = Meneguelo\|first3 = Alexandre\|last3 = Pereira\|first4 = Otaviano R.\|last4 = Mendonça Filho\|first5 = Gilberto Orivaldo\|last5 = Chierice\|first6 = Durvanei Augusto\|last6 = Maria}}</ref>		Research is being conducted with ] cells in-vitro to see if phosphoethanolamine could be used in cancer treatment.<ref>{{Cite journal\|title = Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study\|url = http://www.ncbi.nlm.nih.gov/pubmed/22213293\|journal = Anticancer Research\|date = 2012-01-01\|issn = 1791-7530\|pmid = 22213293\|pages = 95-104\|volume = 32\|issue = 1\|first = Adilson Kleber\|last = Ferreira\|first2 = Renato\|last2 = Meneguelo\|first3 = Alexandre\|last3 = Pereira\|first4 = Otaviano R.\|last4 = Mendonça Filho\|first5 = Gilberto Orivaldo\|last5 = Chierice\|first6 = Durvanei Augusto\|last6 = Maria}}</ref>

			There has been ongoing controversy and litigation in Brazil with regard to its use as a cancer treatment.<ref>{{cite journal \|url=http://www.nature.com/news/brazilian-courts-tussle-over-unproven-cancer-treatment-1.18864 \|title=Brazilian courts tussle over unproven cancer treatment \|author=Heidi Ledford \|date=24 November 2015 \|work=Nature \|doi=10.1038/527420a}}</ref><ref>{{cite journal \|url=http://science.sciencemag.org/content/352/6281/18 \|title=Brazil bill would legalize renegade cancer pill \|work=Science \|doi=10.1126/science.352.6281.18}}</ref>

	{{expand section\|date=March 2016}}		{{expand section\|date=March 2016}}

Revision as of 16:09, 9 April 2016

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Phosphorylethanolamine" – news · newspapers · books · scholar · JSTOR (February 2007) (Learn how and when to remove this message)

Phosphorylethanolamine
Identifiers

CAS Number	1071-23-4
ChEBI	CHEBI:17553
ChEMBL	ChEMBL146972
ChemSpider	990
DrugBank	DB01738
ECHA InfoCard	100.012.717
MeSH	phosphorylethanolamine
PubChem CID	1015
CompTox Dashboard (EPA)	DTXSID5061453
InChI InChI=1S/C2H8NO4P/c3-1-2-7-8(4,5)6/h1-3H2,(H2,4,5,6)Key: SUHOOTKUPISOBE-UHFFFAOYSA-N
Properties
Chemical formula	C₂H₈NO₄P
Molar mass	141.063 g/mol
Appearance	white powder
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references

Chemical compound

Phosphorylethanolamine or phosphoethanolamine is an ethanolamine derivative that is used to construct sphingomyelins. This chemical possesses two pKa values: 5.61 and 10.39.

Research

Research is being conducted with Ehrlich ascites tumor cells in-vitro to see if phosphoethanolamine could be used in cancer treatment.

There has been ongoing controversy and litigation in Brazil with regard to its use as a cancer treatment.

This section needs expansion. You can help by adding to it. (March 2016)

References

Myller, AT et al. 2010 Preparation of aminofunctionalized TiO2 surfaces by binding of organophosphates; Applied Surface Science 257,1616
Ferreira, Adilson Kleber; Meneguelo, Renato; Pereira, Alexandre; Mendonça Filho, Otaviano R.; Chierice, Gilberto Orivaldo; Maria, Durvanei Augusto (2012-01-01). "Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study". Anticancer Research. 32 (1): 95–104. ISSN 1791-7530. PMID 22213293.
Heidi Ledford (24 November 2015). "Brazilian courts tussle over unproven cancer treatment". Nature. doi:10.1038/527420a.
"Brazil bill would legalize renegade cancer pill". Science. doi:10.1126/science.352.6281.18.

Revision as of 16:23, 2 April 2016 editRod57 (talk \| contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers32,748 editsm →Research: [[← Previous edit		Revision as of 16:09, 9 April 2016 edit undoFgnievinski (talk \| contribs)Autopatrolled, Extended confirmed users66,936 edits Citing Nature and Science about controversial cancer treatment allegations in Brazil.Next edit →
Line 44:		Line 44:
	==Research==		==Research==
	Research is being conducted with ] cells in-vitro to see if phosphoethanolamine could be used in cancer treatment.<ref>{{Cite journal\|title = Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study\|url = http://www.ncbi.nlm.nih.gov/pubmed/22213293\|journal = Anticancer Research\|date = 2012-01-01\|issn = 1791-7530\|pmid = 22213293\|pages = 95-104\|volume = 32\|issue = 1\|first = Adilson Kleber\|last = Ferreira\|first2 = Renato\|last2 = Meneguelo\|first3 = Alexandre\|last3 = Pereira\|first4 = Otaviano R.\|last4 = Mendonça Filho\|first5 = Gilberto Orivaldo\|last5 = Chierice\|first6 = Durvanei Augusto\|last6 = Maria}}</ref>		Research is being conducted with ] cells in-vitro to see if phosphoethanolamine could be used in cancer treatment.<ref>{{Cite journal\|title = Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study\|url = http://www.ncbi.nlm.nih.gov/pubmed/22213293\|journal = Anticancer Research\|date = 2012-01-01\|issn = 1791-7530\|pmid = 22213293\|pages = 95-104\|volume = 32\|issue = 1\|first = Adilson Kleber\|last = Ferreira\|first2 = Renato\|last2 = Meneguelo\|first3 = Alexandre\|last3 = Pereira\|first4 = Otaviano R.\|last4 = Mendonça Filho\|first5 = Gilberto Orivaldo\|last5 = Chierice\|first6 = Durvanei Augusto\|last6 = Maria}}</ref>

			There has been ongoing controversy and litigation in Brazil with regard to its use as a cancer treatment.<ref>{{cite journal \|url=http://www.nature.com/news/brazilian-courts-tussle-over-unproven-cancer-treatment-1.18864 \|title=Brazilian courts tussle over unproven cancer treatment \|author=Heidi Ledford \|date=24 November 2015 \|work=Nature \|doi=10.1038/527420a}}</ref><ref>{{cite journal \|url=http://science.sciencemag.org/content/352/6281/18 \|title=Brazil bill would legalize renegade cancer pill \|work=Science \|doi=10.1126/science.352.6281.18}}</ref>

	{{expand section\|date=March 2016}}		{{expand section\|date=March 2016}}

Misplaced Pages